Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varying KLH-adjuvant Dose Combinations to Explore the Immune Response
NCT05876195Unknown
- Sponsor
- University of Oxford
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of keyhole limpet hemocyanin (7 arms), sponsored by University of Oxford. Primary endpoint: Immunogenicity of subunit KLH at Day 28. Status: unknown.
02
Drugs
keyhole limpet hemocyanin
Beyond the preview
Go deeper on NCT05876195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05876195.